PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
13-Feb-2024 Masimo Announces the First FDA-cleared “Over-the-Counter” Fingertip Pulse Oximeter Businesswire
13-Feb-2024 PointClickCare Simplifies Medication Management in Senior Living Communities with Pharmacy Connect Businesswire
13-Feb-2024 Leading Payments Platform Receives Significant Growth Equity Investment from Questa Capital Businesswire
13-Feb-2024 Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024) Businesswire
13-Feb-2024 EyeBio Announces Positive Visual, Anatomic and Safety Data from First-in-Human Ph1b/2a AMARONE Trial of Restoret at Macula Society Annual Meeting Businesswire
13-Feb-2024 Premier, Inc.’s PINC AI™ Applied Sciences and Datavant Collaborate to Enable Next-Generation Clinical Trials Businesswire
13-Feb-2024 Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer Businesswire
13-Feb-2024 Thermo Fisher Scientific Expands GMP Laboratory Service Offerings with Biosafety Testing Including Mycoplasma Testing Businesswire
13-Feb-2024 Coya Therapeutics Licenses Intellectual Property Rights for Use of Next Generation Immune Modulatory Biologics in Combination with COYA 301 to Enhance Regulatory T Cells (Tregs) in Inflammatory Diseases Businesswire
13-Feb-2024 BioAge Announces $170 Million Oversubscribed Series D Financing to Accelerate Development of Obesity and Metabolic Disease Therapeutics Businesswire
13-Feb-2024 Enable Medicine Appoints Kamni Vijay as Chief Executive Officer Businesswire
13-Feb-2024 VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence Businesswire
13-Feb-2024 Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury Businesswire
13-Feb-2024 Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2023 Results Businesswire
13-Feb-2024 Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round to $147M Businesswire
13-Feb-2024 OliX Pharmaceuticals Commences Patient Dosing in Phase 1 Clinical Trial of OLX75016 for MASH Businesswire
13-Feb-2024 eGenesis and PorMedTec Announce Successful Production of Genetically Engineered Porcine Donors in Japan Businesswire
13-Feb-2024 Amneal to Participate at Upcoming Investor Conference Businesswire
13-Feb-2024 Areteia Therapeutics Announces Additional $75MM in Series A Financing for Oral Dexpramipexole in Eosinophilic Asthma Businesswire
13-Feb-2024 Rocket Pharmaceuticals Announces Update on FDA Review Timeline of KRESLADI™ (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I) Businesswire